9th December 2023
Editorials
Context:
Anaemia is another severe public health problem among women, adolescent girls and young children.
Malnutrition's Ongoing Impact
- Global Economic Concerns: Malnutrition hinders India's global potential, impacting human resources and development, exacerbated by recent crises.
- Alarming Statistics: Despite progress in poverty reduction, malnutrition persists, affecting 14.9% of Indians, with 30% attributed to nutritional deprivation.
- Long-Term Consequences: Malnutrition, especially in children, can lead to physical and mental development issues, emphasizing the need for sustained interventions.
State-Level Disparities and Anaemia Challenge
- State-Wise Malnutrition Variation: NFHS 4 and NFHS 5 comparisons reveal inter-year shifts, exposing variations, and highlighting the absence of single-digit malnutrition rates.
- Anaemia's Pervasive Impact: Anaemia, linked to cognitive and physical health issues, remains a challenge; maternal mortality reduction is possible with proper intervention.
- Policy Recommendations: The 15th Finance Commission's grant and existing schemes aim to address malnutrition, but a sustained, focused approach is crucial at both central and state levels.
Urgent Need for Sectoral Reconsideration
- Budgetary Challenges: Nutrition schemes' budgetary fluctuations impact outcomes; a consistent, sector-specific allocation is needed for effective malnutrition elimination.
- Economic Benefits of Investment: Global studies reveal a 16:1 benefit-cost ratio for nutrition investments; the 16th Finance Commission should reconsider sectoral grants.
- Holistic Approach Needed: Schemes like SakshamAnganwadi and Poshan 2.0 must be complemented with sustained financial support to address current and future malnutrition challenges.
Editorials
Context:
COP28 debates fossil fuels and air quality. Delhi's severe pollution links to climate-induced weather shifts, urging immediate, science-backed solutions.
Air Quality Crisis and Climate Change
- Global Debate at COP28: Fossil fuel discussions at COP28 underscore the intricate link between air pollution and climate change.
- Delhi's Disturbing Scenario: In November 2023, Delhi faced a severe air quality crisis, attributed to diverse factors.
- Call for Global Priority: Addressing air pollution emerges as a global imperative for a healthier planet.
Unraveling Delhi's Pollution Haze
- Stubble Burning Paradox: Despite reduced stubble burning, Delhi witnessed a pollution surge, challenging previous understandings.
- Role of Weather Shifts: Unintended weather changes, possibly linked to climate change, played a pivotal role in Delhi's air quality.
- Changing Climate Patterns: Natural phenomena like El Nino and La Nina influence air quality, impacting regions differently.
Urgent Action Needed
- Local and Global Impact: Severe pollution poses regional health and food security threats, necessitating urgent, science-based emission control.
- COP28's Relevance: The climate meet should address air quality concerns, emphasizing substantial measures over cosmetic fixes.
- Air Shed Approach: Immediate, science-backed steps are vital to target emission sources, moving beyond temporary solutions and geo-engineering.
Editorials
Context:
A recent study exposes rampant sale of unapproved and banned antibiotic FDCs in India, fueling antibacterial resistance; regulatory and market challenges persist.
Alarming Proliferation of Unapproved Antibiotic FDCs
- Concerning Study Findings: Academics reveal in the Journal of Pharmaceutical Policy and Practice that 60.5% of antibiotic Fixed Dose Combinations (FDCs) were unapproved, and 9.9% were banned in India in 2020.
- AMR Threat: Unregulated FDCs contribute to Antibacterial Microbial Resistance (AMR), posing a significant health risk amid rising prevalence in India.
- Medical Rationale for FDCs: FDCs improve patient compliance, especially for diseases like AIDS, enhancing treatment outcomes through combined formulations.
Challenges and Misuse in FDC Production
- Complex Formulation Process: Crafting FDCs, despite known drug safety, poses challenges due to potential side effects and interactions, necessitating a rigorous approval process.
- Industry Exploitation: Indian pharmaceutical firms exploit FDCs to avoid price control laws, introducing a plethora of medically unjustifiable combinations for profit.
- Quality Standards and Price Manipulation: Lack of standards for testing FDC quality benefits manufacturers, allowing self-provided standards; FDCs offer companies a pretext for charging higher prices.
Role of Regulators, Doctors, and Market Dynamics
- Regulatory Gaps: Regulatory shortcomings allow unchecked proliferation of dubious FDCs; manufacturers exploit loopholes in the absence of set standards.
- Market-driven Pseudo-Innovation: FDC strategy incentivizes companies to create pseudo-innovations, enabling higher pricing until market competition catches up.
- Doctor's Role: Doctors, often presuming regulatory diligence, contribute to the issue by prescribing FDCs; a complex interplay of market dynamics demands urgent regulatory intervention.